Publications by authors named "Colin Hickle"

Claim this Profile
P
Preclinical Characterization of XB010: A Novel Antibody-Drug Conjugate for the Treatment of Solid Tumors that Targets Tumor-Associated Antigen 5T4.
Brian A Mendelsohn, Kathleen R Gogas, Jeffrey N Higaki, Willy A Solis, Inna Vainshtein, Colin L Hickle

Mol Cancer Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody-Drug Conjugates.
Stepan Chuprakov, Ayodele O Ogunkoya, Robyn M Barfield, Maxine Bauzon, Colin Hickle

Bioconjug Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel HER2-targeted Antibody-drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure Levels.
Robyn M Barfield, Yun Cheol Kim, Stepan Chuprakov, Fangjiu Zhang, Maxine Bauzon, Colin Hickle

Mol Cancer Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
Melissa A Kachura, Colin Hickle, Sariah A Kell, Atul Sathe, Carlo Calacsan

J Immunol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis